Research ArticleAccepted Articles
Open Access
The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics
Anuja Java and Alfred H.J. Kim
The Journal of Rheumatology January 2023, jrheum.220752; DOI: https://doi.org/10.3899/jrheum.220752
Anuja Java
A. Java, MD, Division of Nephrology, Washington University School of Medicine, St. Louis, Missouri, USA. A.H.J. Kim, MD, PhD, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri, USA. Conflict of Interest: AJ serves on the scientific advisory boards of Alexion, AstraZeneca Rare Disease, and Novartis International AG, and serves as a consultant for Chinook Therapeutics. She is also a Principal Investigator for Apellis Pharmaceuticals. AK reports personal fees from Alexion, AstraZeneca Rare Disease, AstraZeneca, Aurinia Pharmaceuticals Inc., Exagen Diagnostics Inc., GlaxoSmithKline (now GSK plc), Kypha Inc., and Pfizer, and research grant support to Washington University School of Medicine from Foghorn Therapeutics and GSK plc. Corresponding Author: Anuja Java, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8045, St. Louis, Missouri 63110, USA. Email: ajava@wustl.edu.
Alfred H.J. Kim
A. Java, MD, Division of Nephrology, Washington University School of Medicine, St. Louis, Missouri, USA. A.H.J. Kim, MD, PhD, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri, USA. Conflict of Interest: AJ serves on the scientific advisory boards of Alexion, AstraZeneca Rare Disease, and Novartis International AG, and serves as a consultant for Chinook Therapeutics. She is also a Principal Investigator for Apellis Pharmaceuticals. AK reports personal fees from Alexion, AstraZeneca Rare Disease, AstraZeneca, Aurinia Pharmaceuticals Inc., Exagen Diagnostics Inc., GlaxoSmithKline (now GSK plc), Kypha Inc., and Pfizer, and research grant support to Washington University School of Medicine from Foghorn Therapeutics and GSK plc. Corresponding Author: Anuja Java, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8045, St. Louis, Missouri 63110, USA. Email: ajava@wustl.edu.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics
Anuja Java, Alfred H.J. Kim
The Journal of Rheumatology Jan 2023, jrheum.220752; DOI: 10.3899/jrheum.220752